Yan Kong

USPTO Trademark & Patent Filings

Kong Yan

Trademark applications and grants for Yan Kong. Yan Kong has 5 trademark applications. The latest application filed is for "NEWONE"

Company Profile
    Company Aliases
  • Kong Yan
  • Yan Kong
  • yan kong
  • KONG; Yan - Zhuhai Guangdong
  • KONG; Yan - Wuxi CN
  • Kong; Yan - Belle Mead NJ
  • Kong; Yan - Wuxi CN
Entity Type INDIVIDUAL
Address Xin'an Street Bao'an District Shenzhen, Guangdong CHINA 518100

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks Patents
Patent Applications
Patent ApplicationDate
Electric Heater
20220154975 - 17/439294 YU; Bo ;   et al.
2022-05-19
Method for Fast Judging and Optimizing Light Emitting Quality of Light Guide Plate Based on Image Processing Technology
20190272629 - 16/415335 QIAN; Weiying ;   et al.
2019-09-05
EX-VIVO PRIMING FOR GENERATING CYTOTOXIC T LYMPHOCYTES SPECIFIC FOR NON-TUMOR ANTIGENS TO TREAT AUTOIMMUNE AND ALLERGIC DISEASE
20110065187 - 12/899069 Cai; Zeling ;   et al.
2011-03-17
EX-VIVO PRIMING FOR GENERATING CYTOTOXIC T LYMPHOCYTES SPECIFIC FOR NON-TUMOR ANTIGENS TO TREAT AUTOIMMUNE AND ALLERGIC DISEASE
20110065186 - 12/899052 Cai; Zeling ;   et al.
2011-03-17
EX-VIVO PRIMING FOR GENERATING CYTOTOXIC T LYMPHOCYTES SPECIFIC FOR NON-TUMOR ANTIGENS TO TREAT AUTOIMMUNE AND ALLERGIC DISEASE
20110065180 - 12/899029 Cai; Zeling ;   et al.
2011-03-17
Method for fast judging and optimizing light emitting quality of light guide plate based on image processing technology
11,055,839 - 16/415,335 Gao , et al. July 6, 2
2021-07-06
IgE antigenic peptides
8,133,972 - 12/892,060 Cai , et al. March 13, 2
2012-03-13
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
8,133,728 - 12/887,052 Cai , et al. March 13, 2
2012-03-13
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
8,133,726 - 12/899,069 Cai , et al. March 13, 2
2012-03-13
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
8,106,153 - 12/892,068 Cai , et al. January 31, 2
2012-01-31
Patent Grants & Applications

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed